The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: olanzapine     Quarter: 2016Q3

Total Records: 887     Number of Pages: 45

DRUGNAME PT EventCount
OLANZAPINE. Coronary artery disease 2
OLANZAPINE. Decreased activity 2
OLANZAPINE. Defect conduction intraventricular 2
OLANZAPINE. Delusional disorder, persecutory type 2
OLANZAPINE. Depressed mood 2
OLANZAPINE. Diastolic dysfunction 2
OLANZAPINE. Drug ineffective for unapproved indication 2
OLANZAPINE. Drug prescribing error 2
OLANZAPINE. Dysgraphia 2
OLANZAPINE. Electrocardiogram J wave 2
OLANZAPINE. Electrocardiogram J wave abnormal 2
OLANZAPINE. Electrocardiogram PR prolongation 2
OLANZAPINE. Electrocardiogram T wave abnormal 2
OLANZAPINE. Encephalopathy 2
OLANZAPINE. Enterocolitis infectious 2
OLANZAPINE. Erotomanic delusion 2
OLANZAPINE. Erythema 2
OLANZAPINE. Euphoric mood 2
OLANZAPINE. Exercise tolerance decreased 2
OLANZAPINE. Eye movement disorder 2

Total Records: 887     Number of Pages: 45